Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

ExpreS2ion Biotechnologies – Rights Issue 2024

Af Michael FriisHead of Equities
ExpreS2ion Biotech Holding

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

ExpreS2ion Biotechnologies is carrying out a rights issue with preferential rights for existing shareholders, amounting to approximately SEK 60 million. The company published its prospectus the 5 June 2024.

CEO Bent U. Frandsen and CFO Keith Alexander will join us on 14 June at 11.00 and take a deeper dive into details of the rights issue and warrant programs, timetable, rationale for the capital raise, and use of proceeds.

ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines through the use of its non-viral Drosophila S2 cells-based expression system.

Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis, 14.16, 7 June 2024.

AKTIER MED FRIIS - UGE 20 2025
16.05.2025, 12.00
Canatu AGM | CEO's review 15.5.2025
16.05.2025, 11.58 Canatu
Energy Save, Webcast, Q1'25
16.05.2025, 10.00 ES Energy Save Holding
Ascelia Pharma, Audiocast with teleconference, Q1'25
16.05.2025, 10.00 Ascelia Pharma
BTS Group, Webcast with teleconference, Q1'25
16.05.2025, 08.00 BTS Group
Vis alle videoer
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.